Innovative Therapies for Children with Cancer in Europe

ITCC clinical trials

The Clinical Trial Committee

Composition

  • A Committee Chair
  • Up to 11 members ensuring expert representation from leukaemia, extracranial solid and CNS tumours (to assure links with EU Tumour Groups)
  • A Representative of the Sponsor Institutions Committee
  • A Statistician with expertise in early phase clinical trials
  • Birgit Geoerger : Gustave Roussy, Villejuif, France (Chair)
  • Michela Casanova : Istituto Nazionale Tumori, Milano, Italy
  • Francois Doz : Institut Curie, Paris, France
  • Darren Hargrave : GOSH, London, UK
  • Francis Mussai : University of Birmingham, UK
  • Xavier Paoletti : Gustave Roussy, Villejuif, France
  • Andrew Pearson : Institute of Cancer Research, London, UK
  • Beate Wulff : University Hospital Essen, Germany
  • Jochen Roessler : University of Freiburg, Germany
  • Michel Zwaan : Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
  • Lynley Marshall : Royal Marsden, Sutton, UK
  • Nathalie Gaspar : Gustave Roussy, Villejuif, France
  • Lucas Moreno : Hospital del Niño Jesus, Madrid, Spain
  • André Baruchel : Robert Debré, Paris, France

Purpose & Role

  • To oversee the ITCC trials portfolio
  • To receive, review proposals of academic-led or pharma-sponsored trials
  • To develop guidelines and algorithms
  • To develop new designs and methodologies